- Home
- BLDEW vs CVM Comparison
BLDEW vs CVM Comparison
Compare BLDEW & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- CVM
- Stock Information
- Founded
- BLDEW 2014
- CVM 1983
- Country
- BLDEW United States
- CVM United States
- Employees
- BLDEW 281
- CVM N/A
- Industry
- BLDEW Transportation Services
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLDEW Consumer Discretionary
- CVM Health Care
- Exchange
- BLDEW Nasdaq
- CVM Nasdaq
- Market Cap
- BLDEW N/A
- CVM N/A
- IPO Year
- BLDEW N/A
- CVM 1987
- Fundamental
- Price
- BLDEW $0.14
- CVM $0.25
- Analyst Decision
- BLDEW
- CVM
- Analyst Count
- BLDEW 0
- CVM 0
- Target Price
- BLDEW N/A
- CVM N/A
- AVG Volume (30 Days)
- BLDEW 51.0K
- CVM 1.6M
- Earning Date
- BLDEW 03-13-2025
- CVM 05-15-2025
- Dividend Yield
- BLDEW N/A
- CVM N/A
- EPS Growth
- BLDEW N/A
- CVM N/A
- EPS
- BLDEW N/A
- CVM N/A
- Revenue
- BLDEW $241,814,000.00
- CVM N/A
- Revenue This Year
- BLDEW N/A
- CVM N/A
- Revenue Next Year
- BLDEW N/A
- CVM N/A
- P/E Ratio
- BLDEW N/A
- CVM N/A
- Revenue Growth
- BLDEW 12.04
- CVM N/A
- 52 Week Low
- BLDEW $0.30
- CVM $0.18
- 52 Week High
- BLDEW $0.36
- CVM $2.39
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- CVM 48.26
- Support Level
- BLDEW N/A
- CVM $0.18
- Resistance Level
- BLDEW N/A
- CVM $0.24
- Average True Range (ATR)
- BLDEW 0.00
- CVM 0.04
- MACD
- BLDEW 0.00
- CVM 0.01
- Stochastic Oscillator
- BLDEW 0.00
- CVM 50.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.